Region Norrbotten's regional board has decided to propose that the regional council should approve the region offering the NIPT test, with funding to be handled by the council through a decision on a supplementary budget in February 2025. The test will be provided free of charge to pregnant women aged 35 or older, but those under 35 will face a self-cost price of 6,000 kronor. This policy positions Norrbotten, together with Region Blekinge, as one of the only regions in Sweden offering NIPT.
NIPT, which stands for Non-Invasive Prenatal Testing, is a form of fetal diagnostics that analyzes fetal DNA from a maternal blood sample to screen for chromosomal abnormalities. Region Norrbotten already offers fetal diagnostics in the form of two ultrasounds to pregnant women, typically conducted at pregnancy weeks 11–14 and weeks 18–20. The probability of chromosomal abnormalities increases with the woman's age, so fetal diagnostics are primarily aimed at older women, but it is also an option for younger pregnant women.
Fetal diagnostics are not done routinely; it is always the pregnant woman who decides whether it should be carried out or not. Funding for Norrbotten's NIPT program will be managed through the regional council's decision on a supplementary budget in February 2025. In a regional comparison, Norrbotten and Blekinge stand out as exclusive providers of NIPT in Sweden.
Contrasting sharply with Norrbotten's age-based policy, Region Gävleborg is eliminating the age requirement for the NIPT test. Patient response in Gävleborg has been notably positive, with nine out of ten pregnant women choosing the blood test (NIPT) in the region. Several unknowns persist regarding Gävleborg's policy change, including the specific age requirement being eliminated and whether the test will be offered free of charge or at a reduced cost post-elimination.
Further unknowns involve the expected eligibility in Norrbotten, such as how many pregnant women are anticipated to qualify for the free NIPT test based on the age criteria of 35 or older. The implications of these regional policies extend beyond immediate access, potentially paving the way for broader adoption of NIPT across Sweden as other regions observe outcomes in Norrbotten and Gävleborg. The regional board's proposal in Norrbotten is part of a broader effort to enhance prenatal care options, with the NIPT test serving as a complementary tool to existing ultrasound-based diagnostics.
This initiative reflects ongoing discussions in Swedish healthcare about balancing medical need, patient choice, and resource allocation in fetal screening programs. As regions like Norrbotten and Gävleborg implement differing strategies, their experiences may inform future national guidelines on NIPT accessibility and funding models.